Intramural leoimyoma without endometrial cavity distortion may negatively affect the ICSI - ET outcome by Suleyman Guven et al.
Guven et al. Reproductive Biology and Endocrinology 2013, 11:102
http://www.rbej.com/content/11/1/102RESEARCH Open AccessIntramural leoimyoma without endometrial cavity
distortion may negatively affect the
ICSI - ET outcome
Suleyman Guven*, Cavit Kart, Mesut A Unsal and Ersan OdaciAbstract
Background: To assess the impact of intramural fibroids on the intracytoplasmic sperm injection-embryo transfer
(ICSI-ET) cycle outcome, when there is no compression of the endometrial cavity.
Methods: In this retrospective, matched control study, the ICSI-ET outcome of sixty-two patients (Group I) with
intramural fibroid (mean diameter <7 cm) and normal endometrial cavity demonstrated by office hysteroscopy was
compared with matched-control group of patients (n = 301) with no fibroid (Group II). The diagnosis of fibroids was
done by transvaginal ultrasonography.
Results: The mean age in fibroid group was 32.66 +/− 5.30 while this figure was 32.95 +/− 3.98 in control group.
The clinical pregnancy rate was significantly lower in the fibroid group although fibroids not distorting the uterine
cavity (25.8% vs. 39.9%, p = 0.04). In fibroid group the implantation rate was significantly lower than control group
(20.97 +/− 37.93 vs.32.89 +/− 43.18%, p = 0.04). However, spontaneous abortion rate was higher in fibroid group
but it did not reach the significant level (12.5% vs. 9.2%, p > 0.05).
Conclusion: Women having intramural leiomyomas not encroaching on the uterine cavity have unfavorable ICSI/ET
outcomes comparable to those of women without such leiomyomas. Therefore, myomectomy may be a good
option for such patients with intramural fibroids even they do not have any endometrial distortion.
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Uterine fibroids affect 20–50% of women of reproductive
age [1]. They contribute to a variety of clinical problems,
including infertility, recurrent pregnancy loss, menorrha-
gia, and pelvic pressure and fullness, as well as complica-
tions of pregnancy. It was estimated that leiomyomata are
the sole cause of infertility in only 2–3% of cases when all
other factors have been ruled out [2].
Athough the exact mechanism of infertility in women
with myoma is unknown, the theories of pathogenic mech-
anisms include mechanical blockage of tubal ostia impair-
ing sperm or embryo transport through the fallopian tubes,
abnormal vascularization, abnormal endometrial develop-
ment, chronic intracavitary inflammation, an abnormal
endocrine milieu, and increased uterine contractility [3].* Correspondence: drsuleymanguven@yahoo.com
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reproduction in any medium, provided the orThere is a controversy on the impact of uterine leiomyo-
mata on the outcome of assisted reproductive technologies
(ARTs). According to recent review, evidence supports the
concept that submucosal fibroids and intramural fibroids
that distort the endometrial cavity impair in vitro
fertilization (IVF) outcomes. It remains unclear, however,
whether intramural and subserosal fibroids, in the setting
of a normal endometrial cavity, have similar effects [4].
In some studies it was shown that pregnancy and im-
plantation rates were significantly lower in women with
intramural fibroids undergoing IVF/ICSI compared with
age-matched controls [5-9]. On the contrary, it other stud-
ies, it was reported that IVF/ICSI outcome was not af-
fected by the presence of intramural or subserosal fibroids
[10-16].
The purpose of this study was to assess the impact of
intramural fibroids with the diameter of <7 cm that do not
distort the endometrial cavity on the intracytoplasmicLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in terms of pregnancy (PR) and abortion rates (AR).
Methods
Patients and study design
In this retrospective age matched, controlled study the re-
cords of women with uterine fibroids who met the criteria
detailed below from a current assisted reproductive tech-
nology unit of tertiary health center from July 2009 to June
2013 were reviewed. Institutional review board (Karadeniz
Technical University, Faculty of Medicine Clinical Research
Ethic commitee) approval was obtained for this retrospect-
ive study.
The following inclusion criteria were used: 62 primary
infertile women with small uterine intramural (a fibroid
which does not distort the uterine cavity and with <50% of
its protruding into the serosal surface of the uterus), fundal
leiomyomas (mean diameter < 7 cm, as described below)
discovered on initial routine screening transvaginal sonog-
raphy (TVUS) performed in preparation for ICSI-ET and
with normal endometrial cavity demonstrated by office
hysteroscopy (fibroid group) were retrospectively matched
by age and number of collected oocytes with 301 patients
at the same period of treatment (same age and same num-
ber of collected oocytes) who did not demonstrate fibroids
anywhere in the uterus (control group). Only the first cycle
of these patients were included.
Women with subserosal, subserosal plus intramural or
submucosal, and corpus or cervical or intracavitary leio-
myoma were not included in this study. Only women with
single intramural fibroid with diameter of <7 cm were in-
cluded. The patients with multiple fibroids and myoma
with the diameter ≥7.0 cm were excluded from the study.
All patients had >10 mm distance of fibroids from the cav-
ity. Both the fibroid and control groups had no history of
prior myomectomy. All patients in control group were
evaluated with hysterosaphingography or sonohysterogra-
phy for possible endometrial pathologies (polyp, septum,
synechia, or etc.). All patients in fibroid and control group
had male factor or tubal factor infertility.
Uterine fibroid diagnosis
Diagnosis of uterine intramural fibroids was done by TVUS
performed with a multifrequency endovaginal transducer
(Logic p5 Sonography, GE Healthcare, USA). The dimen-
sion of each fibroid was determined from the mean value
(cm) of the two largest diameters.
Defining leiomyomas that do not distort the
uterine cavity
A woman with leomyoma “no compression of the endo-
metrial cavity” was defined as a patient in whom the endo-
metrium–myometrium transition was clearly seen as a
line without distortion of its contours by the presence ofthe fibroids in both TVUS sagittal and transverse multiple
sections of the uterus. Also, findings on an office hysteros-
copy before in ICSI-ET cycle were reported as normal for
all patients with leiomyoma. All the office hysteroscopy
procedures were performed by one of the author within
four months of ICSI-ET cycle.
Ovarian stimulation and patients procedures
All patients were stimulated with luteal phase long proto-
col. Leuprolide acetate (Lucrin, Abbot, Istanbul, Turkey)
was started at the luteal phase. Recombinant-FSH (Gonal F,
Serono, Istanbul, Turkey) was administered in a step-down
protocol and starting with a 225 IU/day after step down
regulation confirmation; and after six days the dose was ad-
justed according to the ovarian response.
Recombinant human chorionic gonadotropin (250 mcgr
SC, Ovitrelle, Serono, Istanbul, Turkey) was administered
when at least two or three follicles reached a mean diam-
eter of 17 mm and the serum estradiol concentration
was >500 pg/mL. Transvaginal oocyte retrieval was sched-
uled 36 hours after HCG injection. ICSI was routinely per-
formed for all M II oocytes as our clinical policy.
The embryos that had seven or more cells, symmetric
blastomeres, and <10% cytoplasmic fragmentation on day
3 post aspiration were scored as good embryos. Only good
quality embryos (single embryo for women age <35 years,
two embryos for women age ≥35 years) were transferred.
Embryo transfers were performed 72 hours after oocyte
retrieval with a Wallace catheter (Sims Portex Ltd., Hythe,
United Kingdom) under ultrasound guidance. Luteal sup-
port was performed with micronized P 800 mg/day vagi-
nally (Crinone 8% vaginal gell, Serono, Istanbul, Turkey),
starting on the day of oocyte retrieval.
Definitions
Clinical pregnancy was defined as presence of a gesta-
tional sac with accompanying fetal heart beat under
ultrasound 4 weeks after embryo transfer. Implantation
rate was defined as the number of gestational sacs ob-
served on ultrasound compared with the number of em-
bryos transferred.
Statistics
The ×2, Fisher exact test, and t test were used for statistical
analysis, which was performed using the SPSS software,
version 13.0 for Windows (SPSS Inc., Chicago, USA). Stat-
istical significance was set at P <0.05.
This retrospective study was conducted without fund-
ing sources susceptible of generating any conflict of
interest.
Results
A comparison of the no fibroid and fibroid groups with
regards to patients’ clinical and laboratory characteristics
Table 2 Comparison of cycle outcome characteristics in
the fibroid and control groups
Characteristics Fibroid group Control group P
value(n = 62) (n = 301)
Fertilization rate (%) 77.35% 74.72% 0.352
Implantation rate (%) 20.97% 32.89% 0.044
Clinical pregnancy rate (%) 16 (25.8%) 120 (39.9%) 0.044
Spontaneous abortion rate (%) 2 (12.5%) 11 (9.2%) 0.651
Live birth rate (%) 11 (17.7%) 93 (30.9%) 0.086
Values are given as number of patients and/or percentage.
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age and numbers oocyte retrieved there were no signifi-
cant differences between the 2 groups (32.66 ± 5.3 years
vs. 32.95 ± 3.98 years, NS, independent sample t-test;
and 9.55 ± 4.34 oocytes vs. 9.11 ± 5.13 oocytes, NS, inde-
pendent sample t-test).
Because only the women with tubal or male factor infer-
tility were included, male factor contributed to the eti-
ology of infertility for most cases in both fibroid and
control groups (85.5% vs. 82.7%, respectively, NS, ×2 test).
Tubal factor was responsible for 14.5% of infertility in the
fibroid group and 17.3% in the control group (NS, ×2 test).
A comparison of ICSI-ET outcome by the presence of
fibrod with the mean diameter 49.61 ± 12.32 cm is given in
Table 2. The clinical pregnancy rate (PR) was significantly
higher in the control than in the fibroid group (39.9% vs.
25.8%, respectively, p = 0.04, ×2 test). In fibroid group the
implantation rate was significantly lower than control
group (20.97 ± 37.93 vs.32.89 ± 43.18%, p = 0.04). The odds
ratio for clinical pregnancy was 0.525 (95% confidence
interval 0.284 – 0.969, p = 0.039). However, the first trimes-
ter spontaneous abortion rates (AR) for clinical pregnan-
cies was 9.2% (2/16) for fibroid and 12.5% (11/120) for
controls (p < 0.05, ×2 test). Furthermore the live birth rates
were not statistically significantly different in both groups
(30.9% (93/301) for no fibroid group, 17.7% (11/62) for fi-
broid group, p > 0.05, ×2 test).
Discussion
The aim of the current study was to determine whether the
presence of intramural fibroids with the diameter of <7 cm
has an influence on the PR and AR after ICSI-ET treat-
ment. In this age matched case control study, it was found
that the clinical PR per transfer was significantly lower in
the group of patients with intramural fibroids, even whenTable 1 Comparison of clinical and laboratory
characteristics in the fibroid and control groups
Characteristics Fibroid group Control group P
value(n = 62) (n = 301)
Age (yr.) 32.95 ± 3.98 32.66 ± 5.3 0.683
Duration of infertility (yr.) 6.43 ± 6.03 5.63 ± 4.51 0.238
Baseline FSH (IU/l) 7.80 ± 3.20 7.29 ± 3.48 0.417
Total antral follicle count (no.) 10.52 ± 3.42 11.20 ± 4.76 0.289
Cause of infertility (%)
Male factor (%) 53 (85.5%) 249 (82.7%) 0.375
Tubal factor (%) 9 (14.5%) 52 (14.5%)
No. of oocyte retrieved (no.) 9.11 ± 5.13 9.55 ± 4.34 0.480
No. of MII oocyte retrieved (no.) 6.89 ± 4.29 6.80 ± 3.54 0.871
No. of embryo transferred (no.) 1.39 ± 0.49 1.40 ± 0.49 0.866
Values are given as mean ± SD or number of patients (percentage) unless
otherwise indicated.there was no deformation of the uterine cavity. However
the AR was not significantly affected by the presence of
intramural fibroids.
Although many studies have investigated the impact of
intramural and subserosal fibroids on IVF outcomes, the
effect of intramural fibroids not distorting intrauterine
cavity is controversial issue. One recent prospective study
results [17] are in agreement with our study. This study
compared 112 women with intramural fibroids less than
5 cm in size with 322 women without fibroids. The preg-
nancy, ongoing pregnancy and live birth rates in the study
group were 23.6, 18.8 and 14.8% compared with 32.9, 28.5
and 24% in the control group, respectively (P < 0.05) [17].
Recent meta-analysis also suggested that the presence of
non-cavity-distorting intramural fibroids were associated
with lower clinical pregnany and live birth rates in women
undergoing IVF treatment [18].
A recent prospective study results [15] were also well
correlated with our study, although the difference has not
been reached statistically significant value. This study com-
pared 61 patients with intramural fibroids less than 5 cm
with 61 matched controls. All participants had normal
endometrial cavities on hysterosalpingogram, the average
fibroid size was 1.5 cm. Compared with the controls, the fi-
broid group had lower implantation rates (13.6% versus
20.2%), lower pregnancy rates (34.4% versus 47.5%), and
higher miscarriage rates (33.3% versus 20.7%), which
highlighted the potential negative impact of small intra-
mural fibroids on IVF outcomes [15].
A recent systematic literature review concerning the ef-
fect of fibroids on fertility in patients undergoing ART
evaluated six articles and concluded that there was a sig-
nificant negative impact on implantation rate in the intra-
mural myoma groups vs. the control groups (16.4 vs.
27.7% OR 0.62 (0.48-0.8)). The pregnancy and delivery
rates per transfer cycle were also significantly lower in my-
oma groups. It was concluded that a surgical approach in
patients with a history of previous failed attempts with
intramural myomata >2 cm in diameter is warranted if all
ather factors have been evaluated [9]. Morover, Kolankaya
et al. also suggested that there is no consensus for intra-
mural myomas that do not enroach upon the cavity;
Table 3 Outcome of ART cycles in women with intramural fibroids and in a control group (without myoma), reporting **significant and *non-significant results

















Stovall et al. [6]** 1998 Prospective IVF/ET
and ZIFTb
10-54 91 (SS 5, IM 86) 46/334a (13.8%) 34/91a (37.4%) 4/34 (11.8%) 91 65/330a (19.7%) 48/91a (52.7%) 4/48 (8.3%)
Eldar-Geva et al. [5]** 1998 Retrospective
IVF/ET and GIFTb
23.7 ± 7.1 55 IM NAa (6.4%) 9/55a (16.4%) 3/9 (33.3%) 318 NAa (15.8%) 98/318a (30.8%) 20/98 (20.4%)
Hart et al. [20]** 2001 Prospective IVF/ICSI ≤50 86 (IM or SS) NAa (11.9%) 20/86a (23.3%) 4/20 (20.0%) 290 NAa (20.2%) 99/290a (34.1%) NA
Surrey et al. [8]** 2001 Retrospective IVF/ET
(Age <40 y)
20 ± 2 51 IM 36/168a (21.4%) 27/51 (52.9%) 2/27 (7.4%) 257 265/796a (33.3%) 166/268 (61.9%) 12/166 (7.2%)
Gianaroli et al. [21]** 2005 Retrospective
IVF/ICSIb
18 ± 14 75 IM 48/267a (18.0%) 45/129 (34.9%) 18/45a (40.0%) 127 63/238a (26.5%) 53/129 (41.1%) 10/53a (18.9%)
Girgin et al. [22]* 2005 Retrospective
IVF/ICSIb
30-60 95 IM NA 26/95a (27.4%) 2/26 (7.7%) 100 NA 43/100a (43.0%) 2/43 (4.7%)
Khalaf et al. [17]** 2006 Prospective IVF/ICSI 23 ± 11 112 (IM or SS) NA NAa (23.6%) NA 322 NA NAa (32.9%) NA
Farhi et al. [23]* 1995 Retrospective
IVF/ETb
NA 28 IM/SS mix 31/471 (6.6%) 25/86 (29.0%)b 10/25 (40.0%) 50 37/317 (11.7%) 32/127 (25.2%)c 8/32 (25.0%)
Ramzy et al. [10]* 1998 Retrospective
IVF/ICSI b
3.2 ± 1.1 39 (SS 32, IM 12) 16/128 (12.5%) 15/39 (38.5%) 3/15 (20.0%) 367 165/1192 (13.8%) 123/367 (33.5%) 19/123 (15.5%)
Dietterich et al. [11] * 2000 Retrospective
IVFb (Age >35 y)
10-20 9 (IM or SS) NA (33.0%) NA (56.0%) NA NA NA (32.7%) NA (64.0%) NA
Jun et al. [12]* 2001 Retrospective IVF < 70 141 (IM or SS or SM) NA 43/141 (30.5%) 8/43 (18.6%) 406 NA 169/406 (41.6%) 22/169 (13.0%)
Yarali et al. [14]* 2002 Retrospective
ICSI/ETb
50-100 73 IM 18/183 (9.8%) 16/73 (21.9%) 1/16 (6.2%) 324 102/911 (11.2%) 90/324 (27.8%) 6/90 (6.6%)
Ng et al. [13]* 2002 Prospective IVF/ET 25-97.5 77 (SS or IM) 22/159 (13.8%) 20/77 (26.0%) 4/20 (20.0%) 312 62/638 (14.4%) 74/312 (23.7%) 6/74 (8.1%)
Check et al. [17]* 2002 Prospective IVF/ETb ≤ 50 61 (IM 32, SS
plus IM 19)
27/208 (13.6%) 21/61 (34.4%) 7/21 (33.3%) 61 41/203 (20.2%) 29/61 (47.5%) 6/29 (20.7%)
Oliveira et al. [17]* 2004 Retrospective
IVF/ICSIb
< 70 130 IM NA 63/130 (48.5%) 17/63 (27.0%) 245 NA 110/245 (44.9%) 31/110 (28.2%)
Ballesteros et al. [24]* 2006 Retrospective IVF < 50 65 cycle (IM or SS) NA NA (20.0%) NA (46.1%) 366 cycle NA NA (23.2%) NA (29.4%)
Klatsky et al. [25]* 2007 Retrospective IVF 28d 94 (IM, SS or
IM plus SS)
NA (36%) 44/94 (47.0%) 8/44 (15.0%) 275 NA (36%) 149/275 (54.0%) 14/149 (9.0%)
Bozdag et al. [26]* 2009 Retrospective ICSI 5-43 61 IM 33/162 (20%) 22/61 (36%) 6/22 (27%) 444 250/1299 (19%) 167/444 (38%) 31/167 (19%)
Somigliana et al.
[27]*
2011 Prospective IVF/ICSI 50 119 (IM or SS) NA (17%) 26/119 (22%) 6/28 (21%) 119 NA (11%) 22/119 (19%) 6/22 (27%)
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they are larger than 7 cm or are associated with multiple
failed IVF cycles [19]. Only a few reports showed the sig-
nificant detrimental effect of intramural myoma on ART
outcome as detailed in Table 3 [5,6,20]. However, meta-
analysis results of all reported studies showed the negative
effect of fibroid on pregnancy rates (Figure 1, odds ratio
0.737, 95% confidence interval 0.647-0.840, p = 0.000).
In contrast, according to systematic review of the evi-
dence reported by Pritts et al. [3] those women with only
intramural fibroids had relative risks of pregnancy, im-
plantation and delivery of 0.94 (95% CI 0.73–1.20), 0.81
(95% CI 0.60–1.09) and 1.01 (95% CI 0.73–1.34), respect-
ively, when compared with their infertile counterparts
without fibroids in in vitro fertilization cycles [3]. Further-
more Surrey et al. [28] recommended that submucosal
leiomyomas and intramural leiomyomas which distort the
endometrial cavity would have deleterious effects on im-
plantation and IVF cycle outcome. However, the effect of
intramural leiomyomata which do not distort the cavity is
much more difficult to evaluate. Conflicting conclusions
from various investigators made difficult to recommend
routine myomectomy for all intramural lesions before
IVF/ICSI cycle [28]. Many retrospective and only a few
prospective matched control studies failed to reveal signifi-
cant detrimental effect of intramural myoma on IVF/ICSI
outcome as detailed in Table 3 [8-10,12-16]. The failed sig-
nificant detrimental effect of myoma on reproduction may
be explained with the lack of better classification system of
myoma. The wide use of new FIGO classification system
(PALM-COEIN) for causes of abnormal uterine bleeding
and leimyoma subclassification system [29] in the world
may help to elucidate the effect of leoimyoma notFigure 1 Outcomes, meta-analysis results of all reported studies on p
control group (without myoma).distorting endometrial cavity on pregnancy and implant-
ation rates.
The effect of intramural fibroids not distorting endomet-
rial cavity was also investigated in oocyte donation cycles
in order to rule out the effect of ovarian stimulation on
endometrial receptivity as well as the detrimental effect of
age on oocyte quality. The authors failed to reveal detri-
mental effect of myoma on clinical pregnancy and implant-
ation rates, although they reported alteration in the
expression pattern of some endometrial genes [30]. The ef-
fect of submucosal myoma on endometrial gene expression
was also investigated and the recent study reported that
submucosal myomas adversely affect reproduction by de-
creasing endometrial HOX gene expression [4].
The mechanisms by which myomas may affect repro-
ductive outcome are as follows: interference with sperm
transport or access (by anatomic distortion of the cervix,
enlarging or deforming the endometrial cavity, altering the
uterine contractility, and obstructing tubal ostia) or im-
plantation failure (by physically changing the shape of the
endometrium, preventing discharge of intrauterine blood
or clots, and altering the normal endometrial development
(endometrial vascular disturbances, inflammation, ulcer-
ation, thinning, and atrophy and altered biochemical en-
vironment)) [4,19]. Intramural myomas particularly <7 cm
in size may alter myometrial contraction during ET pro-
cedure and cause negative effect on implantation, preg-
nancy and abortion rates following ICSI/ET cycles, even
they do not impinge the endometrial cavity.
Ng et al. [13] reported that the presence of fibroids re-
sulted in significantly reduced uterine artery pulsatility
and resistance index [13]. Based on this study it may be
suggested that the blood flow towards the endometriumregnancy rates in women with intramural fibroids and in a
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wards fibroids. This effect may explain the detrimental ef-
fect of myoma on implantation and pregnancy rates in
ICSI/ET cycles.
In this retrospective controlled study, the effect of single
intramural myoma (<7 cm) not distorting endometrial cav-
ity was investigated and we found that the fibroid group
had lower implantation ad pregnancy rates. This may sug-
gest the detrimental effect of myoma on reproduction. As
seen in Table 3, the significant detrimental effect of such
size myoma on reproduction has not been reported previ-
ously. However, the main limitations of this study are the
limited size of groups and the retrospective study design.
In order to make a certain conclusion regarding intramural
fibroids below 7 cm in size not distorting intrauterine cav-
ity, a randomized controlled trial (RCT) of myomectomy
versus no therapy should be performed in ICSI/ET cycles.
Furthermore, the best study to determine the effects of
intramural fibroids on the ART outcome would be a pro-
spective cohort study and then a RCT would best demon-
strate any possible benefit of myomectomy to mitigate
these potentially detrimental effects.
Conclusions
Based on our preliminary results of this study, although
significant results were obtained in terms of implantation
and pregnancy rates, it is not easy to advocate removal
of intramural fibroids to improve fertility before ART cy-
cles, since there are many potential complication associ-
ated with myomectomy, such as infection, bleeding, possibly
blood transfusion, damage to abdominal or pelvic organs,
formation of intraabdominal adhesions and anesthesia re-
lated complications and possible subsequent pregnancy com-
plications [9]. However, the current study significant results
in terms of implantation and pregnancy rates may suggest
the possible positive effect of myomectomy on ICSI/ET out-
come for only particular myoma size.
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